April 1 (Reuters) - Surrozen Inc SRZN.O :
* SURROZEN ANNOUNCES UP TO $192.5 MILLION PRIVATE PLACEMENT
OF
SECURITIES PRICED AT-THE-MARKET UNDER NASDAQ RULES
* SURROZEN INC - INITIAL CAPITAL FUNDS EXPANSION OF PHASE 1B
TRIAL
IN SEVERE ALCOHOL-ASSOCIATED HEPATITIS AND EXTENDS CASH RUNWAY
* SURROZEN INC - PHASE IB DATA IN EXPANDED STUDY EXPECTED IN
1H
2025
* SURROZEN INC - INTENDS TO USE NET PROCEEDS FROM PRIVATE
PLACEMENT TO FUND SZN-043 CLINICAL DEVELOPMENT PROGRAM
Source text for Eikon: ID:nGNX98087w
Further company coverage: SRZN.O
((Reuters.Briefs@thomsonreuters.com;))